C-Abl Regulates Estrogen Receptor Α Transcription Activity Through Its Stabilization by Phosphorylation

X He,Z Zheng,T Song,C Wei,H Ma,Q Ma,Y Zhang,Y Xu,W Shi,Q Ye,H Zhong

DOI: https://doi.org/10.1038/onc.2009.513

IF: 8.756

2010-01-01

Oncogene

Abstract:Estrogen receptors are members of the steroid hormone superfamily of nuclear receptors that act as ligand-activated transcription factors. Similar to other steroid hormone receptors, estrogen receptor α (ERα) is a substrate for protein kinases, and phosphorylation has profound effects on the function of this receptor. In this study, we show that ERα associates with c-Abl nonreceptor tyrosine kinase. The direct interaction is mediated by two PXXP motifs of ERα and the c-Abl SH3 domain. Mutational analysis and in vitro kinase assays show that ERα can be phosphorylated on two sites, tyrosine 52 (Y-52) and tyrosine 219 (Y-219). ERα phosphorylation by c-Abl stabilizes ERα, resulting in enhanced ERα transcriptional activity and increased expression of endogenous ERα target genes. Furthermore, ERα phosphorylation at the Y-219 site affects DNA binding and dimerization by ERα. Both the c-Abl inhibitor and the c-Abl kinase dead mutation abolish the c-Abl-induced accumulation of ERα and enhancement of ERα transcriptional activity, indicating that c-Abl kinase activity is required for regulation of the ERα function. Moreover, the ERα (Y52,219F) mutant shows reduced breast cancer cell growth and invasion. Taken together, these results show that c-Abl is a novel kinase that upregulates ERα expression and promotes breast cancer cell proliferation, suggesting a great potential for this kinase to function as a therapeutic target for breast cancer.